135P * SIGNIFICANCE OF THYROID TRANSCRIPTION FACTOR 1 EXPRESSION IN PATIENTS WITH NONSQUAMOUS NSCLC TREATED WITH PEMETREXED BASED CHEMOTHERAPY
Mielgo, X., Velastegui Ordonez, A., Martinez Cabanes, R., Rosero, A. C., Ruiz-Gimenez, L., Camara, J. C., Hernando, S., Hurtado, A., Olier, C.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv050.39
Date:
April, 2015
File:
PDF, 29 KB
english, 2015